US 7,569,610 B2 · Modified release formulations of a bupropion salt

Abstract

The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.

Claims5

Dependent claims

A method of treating depression, comprising administering an effective amount of bupropion hydrobromide to treat depression to a subject in need thereof.

Dependencies are inferred from the claim text.

Facts

Application

11/751,768Filed 22 May 2007 · continuation

Priority

27 Jun 2005

Published

US 2007/0027213 A129 Nov 2007

Granted

4 Aug 2009

Term ends

Not estimatedThe source records don’t support an estimate.

Classification27 codes

A61K 9/0004
Galenical forms characterised by the drug release technique; Application systems commanded by energy: osmotic delivery systems; Sustained release…
A61K 9/2027
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/28
Pills, tablets, discs, rods: dragees; Coated pills or tablets , e.g. with film or compression coating
A61K 9/2846
Obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone: polyacrylates

Family

Application60/693,906Us provisional application · filed 27 Jun 2005

Application11/475,252Parent of this continuation · filed 27 Jun 2006

US 2007/0276047 A1Pre-grant publication · published 29 Nov 2007

US 7,241,805 B2Parent of this continuation

US 2007/0027213 A1Published application

US 7,569,610 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

11/751,768Filed 22 May 2007 · continuation

Priority

27 Jun 2005

Published

US 2007/0027213 A129 Nov 2007

Granted

4 Aug 2009

Term ends

Not estimatedThe source records don’t support an estimate.

Classification27 codes

A61K 9/0004
Galenical forms characterised by the drug release technique; Application systems commanded by energy: osmotic delivery systems; Sustained release…
A61K 9/2027
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/28
Pills, tablets, discs, rods: dragees; Coated pills or tablets , e.g. with film or compression coating
A61K 9/2846
Obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone: polyacrylates

Family

Application60/693,906Us provisional application · filed 27 Jun 2005

Application11/475,252Parent of this continuation · filed 27 Jun 2006

US 2007/0276047 A1Pre-grant publication · published 29 Nov 2007

US 7,241,805 B2Parent of this continuation

US 2007/0027213 A1Published application

US 7,569,610 B2This patent

From the US filing history. Foreign family members aren’t listed.

Modified release formulations of a bupropion salt

Life of this patent

Abstract

Claims5

Modified release formulations of a bupropion salt

Life of this patent

Abstract

Claims5